Krystal Biotech Inc
KRYS
Market Cap$5.33B
Close$
$28.58
84.6% downside
Current Fair Value
84.6% downsideOvervalued by 84.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.33 Billion |
|---|---|
| Enterprise Value | $4.96 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.4 |
| Beta | 0.82 |
| Outstanding Shares | 28,716,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 101.57 |
|---|---|
| PEG | -153.11 |
| Price to Sales | 23.16 |
| Price to Book Ratio | 6.18 |
| Enterprise Value to Revenue | 20.52 |
| Enterprise Value to EBIT | 78.08 |
| Enterprise Value to Net Income | 94 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data